CHEMED CORPORATION Business Acquisition, Pro Forma Revenue
CHEMED CORPORATION (CHE) reported Business Acquisition, Pro Forma Revenue of $528.30 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-04.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2021-02-26
- CHEMED CORPORATION business acquisition, pro forma revenue for the quarter ending 2020-09-30 was $528.30M, a 5.60% increase year-over-year.
- CHEMED CORPORATION business acquisition, pro forma revenue for the quarter ending 2020-06-30 was $502.39M, a 1.32% increase year-over-year.
- CHEMED CORPORATION business acquisition, pro forma revenue for the quarter ending 2019-12-31 was $515.26M, a 7.42% increase year-over-year.
- CHEMED CORPORATION business acquisition, pro forma revenue for the quarter ending 2019-09-30 was $500.29M, a 5.97% increase year-over-year.
- CHEMED CORPORATION business acquisition, pro forma revenue for fiscal 2019 was $2.00B, a 5.02% increase from fiscal 2018.
- CHEMED CORPORATION business acquisition, pro forma revenue for fiscal 2018 was $1.90B.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 3 month as first filed | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 9 month as first filed | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|---|---|
| 2020-09-30 | $528.30M 10-Q · filed 2020-11-04 | $1.03B derived: sum of 2 quarters · filed 2020-11-04 | $1.55B 10-Q · filed 2020-11-04 | |||
| 2020-06-30 | $502.39M 10-Q · filed 2020-07-31 | $1.02B 10-Q · filed 2020-07-31 | ||||
| 2019-12-31 | $515.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.02B derived: sum of 2 quarters · filed 2021-02-26 | $1.51B derived: sum of 3 quarters · filed 2021-02-26 | $2.00B 10-K · filed 2021-02-26 | ||
| 2019-09-30 | $500.29M 10-Q · filed 2020-11-04 | $500.11M 10-Q · filed 2019-11-04 | $996.14M derived: sum of 2 quarters · filed 2020-11-04 | $1.48B 10-Q · filed 2020-11-04 | $1.48B 10-Q · filed 2019-11-04 | $1.96B derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $495.85M 10-Q · filed 2020-07-31 | $980.14M 10-Q · filed 2020-07-31 | $1.46B derived: sum of 3 quarters · filed 2021-02-26 | $1.93B derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2019-03-31 | $484.11M 10-Q · filed 2020-05-01 | $963.79M derived: sum of 2 quarters · filed 2021-02-26 | $1.44B derived: sum of 3 quarters · filed 2021-02-26 | |||
| 2018-12-31 | $479.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $951.77M derived: sum of 2 quarters · filed 2021-02-26 | $1.90B 10-K · filed 2021-02-26 | |||
| 2018-09-30 | $472.09M 10-Q · filed 2019-11-04 | $1.42B 10-Q · filed 2019-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |